LKL International Bhd (XKLS:0182) 3-Year RORE % : 14.22% (As of Mar. 2026)


What is LKL International Bhd 3-Year RORE %?

LKL International Bhd XKLS:0182 3-Year RORE % is 14.22 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 777 Medical Devices & Instruments companies, LKL International Bhd ranks better than 68.98% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. LKL International Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 was 14.22%.

The industry rank for LKL International Bhd's 3-Year RORE % or its related term are showing as below:

XKLS:0182's 3-Year RORE % is ranked better than
68.98% of 777 companies
in the Medical Devices & Instruments industry
Industry Median: -4.03 vs XKLS:0182: 14.22

LKL International Bhd  (XKLS:0182) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


LKL International Bhd 3-Year RORE % Related Terms


LKL International Bhd 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for LKL International Bhd's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LKL International Bhd 3-Year RORE % Chart

LKL International Bhd Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Sep22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 676.47 0.00 5.00 0.00 22.16

LKL International Bhd Quarterly Data
Oct20 Jan21 Jul21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.06 62.77 37.50 22.16 14.22

XKLS:0182 vs ISRG, BDX, MDLN: 3-Year RORE % Comparison

For the Medical Instruments & Supplies subindustry, LKL International Bhd's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LKL International Bhd 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where LKL International Bhd's 3-Year RORE % falls into.



LKL International Bhd 3-Year RORE % Calculation

LKL International Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.074--0.045 )/( -0.204-0 )
=-0.029/-0.204
=14.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 14.22 mean?
LKL International Bhd (XKLS:0182) has a 3-Year RORE % of 14.22 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on LKL International Bhd and its competitors. According to the industry distribution chart, LKL International Bhd ranks #241 out of 777 companies in the Medical Devices & Instruments industry, placing it in the top 31%.
Is LKL International Bhd's 3-Year RORE % too high?
LKL International Bhd's current 3-Year RORE % is 14.22. Based on the distribution chart, LKL International Bhd ranks #241 out of 777 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does LKL International Bhd's 3-Year RORE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, LKL International Bhd ranks #241 out of 777 companies for 3-Year RORE %. This puts LKL International Bhd in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on LKL International Bhd and its competitors. LKL International Bhd's current 3-Year RORE % is 14.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.03 — trading 40% below its estimated fair value. The current 3-Year RORE % is 14.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current 3-Year RORE % is 14.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LKL International Bhd Business Description

Address Wisma LKL, No.3, Jalan BS 7/18, Kawasan Perindustrian Bukit Serdang, Seksyen 7, Seri Kembangan, SGR, MYS, 43300
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.